Afatinib Not Yet Recruiting Phase 1 / 2 Trials for EGFR Mutation Positive Non Small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs